Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 6/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | CCR1 | P32246 | 2/20 | 0.38 |
| ▸ | CCR5 | P51681 | 2/20 | 0.38 |
| ▸ | CCR8 | P51685 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | METAP1 | P53582 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.38 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30462892 | 1.00 | ALOX5 (0.47) | ALOX5KDM4ELMNACCR1CCR5 | |
| SCHEMBL18048017 | 0.84 | ALOX5 (0.50) | ALOX5CYP1A2POLBTP53SMN1; SMN2 | |
| SCHEMBL4074615 | 0.82 | ALOX5 (0.47) | ALOX5KDM4ELMNACCR1CCR5 | |
| SCHEMBL27903683 | 0.81 | ALOX5 (0.41) | ALOX5KDM4ELMNACYP1A2SMN1; SMN2 | |
| SCHEMBL28562737 | 0.79 | ALOX5 (0.44) | ALOX5CYP1A2POLBSMN1; SMN2TDP1 | |
| SCHEMBL28363259 | 0.79 | ALOX5 (0.43) | ALOX5KDM4ELMNACCR1CCR5 | |
| SCHEMBL29390749 | 0.79 | ALOX5 (0.43) | ALOX5KDM4ELMNACCR1CCR5 | |
| SCHEMBL18076935 | 0.78 | ALOX5 (0.43) | ALOX5KDM4ELMNACCR1CCR5 | |
| SCHEMBL23322424 | 0.78 | ALOX5 (0.43) | ALOX5CYP1A2POLBBLMTP53 | |
| SCHEMBL31059186 | 0.78 | ALOX5 (0.43) | ALOX5CYP1A2POLBBLMTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110867587-B | Neutral water system mixed liquid flow battery with high power and long service life based on pyridylphenoxazine | 常州大学 | 2022-03-01 | — | — | CN | claimed |
| CN-110867587-A | Neutral water system mixed liquid flow battery with high power and long service life based on pyridylphenoxazine | 常州大学 | 2020-03-06 | — | — | CN | claimed |
| CN-110867587-B | Neutral water system mixed liquid flow battery with high power and long service life based on pyridylphenoxazine | 常州大学 | 2022-03-01 | — | — | CN | disclosed |
| CN-110867587-B | Neutral water system mixed liquid flow battery with high power and long service life based on pyridylphenoxazine | 常州大学 | 2022-03-01 | — | — | CN | disclosed |
| CN-110867587-B | Neutral water system mixed liquid flow battery with high power and long service life based on pyridylphenoxazine | 常州大学 | 2022-03-01 | — | — | CN | disclosed |
| CN-110867587-A | Neutral water system mixed liquid flow battery with high power and long service life based on pyridylphenoxazine | 常州大学 | 2020-03-06 | — | — | CN | disclosed |
| CN-110867587-A | Neutral water system mixed liquid flow battery with high power and long service life based on pyridylphenoxazine | 常州大学 | 2020-03-06 | — | — | CN | disclosed |
| CN-110867587-A | Neutral water system mixed liquid flow battery with high power and long service life based on pyridylphenoxazine | 常州大学 | 2020-03-06 | — | — | CN | disclosed |
| EP-3268489-A1 | FLUOROGENIC AND CHROMOGENIC SUBSTRATE | LI-COR, INC. (US) | 2018-01-17 | — | — | EP | disclosed |
| US-9632034-B2 | Fluorogenic and chromogenic substrate | LI-COR, INC. (US) | 2017-04-25 | — | — | US | disclosed |
| WO-2016149127-A1 | FLUOROGENIC AND CHROMOGENIC SUBSTRATE | LI-COR, INC. (US) | 2016-09-22 | — | — | WO | disclosed |
| EP-1874731-A2 | QUINOBENZOXAZINE ANALOGS AND METHODS OF USING THEREOF | Cylene Pharmaceuticals, Inc. (US) | 2008-01-09 | — | — | EP | disclosed |
| US-7176307-B2 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20060264634-A1 | Quinobenzoxazine analogs and methods of using thereof | CYLENE PHARMACEUTICALS, INC. | 2006-11-23 | — | — | US | disclosed |
| WO-2006113509-A2 | QUINOBENZOXAZINE ANALOGS AND METHODS OF USING THEREOF | CYLENE PHARMACEUTICALS, INC. (US) | 2006-10-26 | — | — | WO | disclosed |
| US-20060106211-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2006-05-18 | — | — | US | disclosed |
| US-7041390-B2 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2006-05-09 | — | — | US | disclosed |
| CN-1751055-A | Organic metal complex, electroluminescent material using the complex and ectroluminescent element using the complex | SEMICONDUCTOR ENERGY LAB (JP) | 2006-03-22 | — | — | CN | disclosed |
| EP-1598361-A1 | ORGANIC METAL COMPLEX, ELECTROLUMINESCENT MATERIAL USING THE COMPLEX AND ECTROLUMINESCENT ELEMENT USING THE COMPLEX | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2005-11-23 | — | — | EP | disclosed |
| US-20050006625-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264634-A1 | Quinobenzoxazine analogs and methods of using thereof | CYP2W1, NQO2, UGT2B7 | ALOX5 329/4885KDM4E 1852/4885LMNA 2466/4885 |
| US-20050006625-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | HSF1, ELP1, RPL19 | ALOX5 1416/4885KDM4E 1999/4885LMNA 4376/4885 |
| US-20060106211-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | ELP1, HSF1, EMC1 | ALOX5 1822/4885KDM4E 1938/4885LMNA 4405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.